They found 5+/41 reactions and identified two types of fusions via sequencing: (i) CML-specific BCR-ABL1 p210: b2a2, b3a2 fusions and (ii) atypical fusions which were probably non-functional. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.